When collaborating in the healthcare sector, we always act ethically, transparently and in accordance with Swiss laws, regulations and the obligations of the industry association.
AbbVie works with healthcare professionals, healthcare organisations and patient organisations to improve the health of patients worldwide.
Our exchanges with healthcare professionals, healthcare organisations and patient organisations are characterised by openness and transparency in order to build public trust and create reliability. AbbVie discloses these business relationships to demonstrate its integrity in its collaboration with healthcare professionals, healthcare organisations and patient organisations.
The exchanges with healthcare professionals, healthcare organisations and patient organisations leads to new and better therapies and, above all, better patient care. We believe that engaging with healthcare professionals and healthcare organisations is essential to advancing patient care, identifying gaps in medical care and driving forward the development of new medicines. Cooperation is based on trust, transparency and integrity.
Our aim is to give the public an insight into these interactions in order to strengthen trust and demonstrate reliability. AbbVie engages in various activities, from clinical research to sponsorship and educational activities, to share information on how new medicinal products can be integrated into the treatment pathway. By being transparent about these relationships, AbbVie emphasises its ongoing commitment and strengthens the foundation for future collaborations.
On 2 May 2022, the local legal entities of AbbVie (AbbVie AG) and Allergan (Allergan AG) were merged or the business transferred in Switzerland. The overview of Allergan AG's services can be accessed by clicking on this link.
AbbVie is committed to making a real difference in the lives of patients and their families. We combine cutting-edge science with a deep understanding of patients' experiences and healthcare systems to help people live better lives. We want to learn more about the experiences of patients in order to understand the problems, concerns and priorities of people affected by a disease.
Patient organisations are a valuable source of information and support for patients and their families. We foster relationships with patient organisations based on mutual trust, respect and shared goals that meet AbbVie's standards of conduct in the areas of transparency and ethics. Through these relationships, AbbVie helps to inform patients and their families about disease patterns and ways to improve quality of life. These partnerships promote dialogue between interest groups and contribute towards the creation of new, cost-effective care models.
AbbVie publishes an annual list of financially supported Swiss patient organisations. The publication of the following reports illustrates our commitment to transparent disclosure of our financial relationships with patient organisations.
Pharma Code: Code of Conduct of the Pharmaceutical Industry in Switzerland of 4 December 2003, revised on 14 May 2020.
Pharma Cooperation Code: Code of Conduct of the Pharmaceutical Industry in Switzerland on Cooperation with Healthcare Professionals and Patient Organisations of 6 September 2013, revised on 14 May 2020.
The AbbVie webpage you have requested is only intended for certain countries. (You will find the relevant information on the page.) Therefore, the website may contain information on medicinal products, other products or uses of these products that are not authorised in other countries or regions. If the latter applies to you, please contact your AbbVie national subsidiary to obtain the correct product information for your country. The AbbVie webpage you have requested is not in German. The AbbVie webpage you have requested may not be optimised for your screen size. Would you like to continue?